Safety Outcomes of Tenecteplase Compared With Alteplase in Acute Ischemic Stroke: A Multicenter Retrospective Real-World Study
Published online on February 19, 2026
Abstract
Journal of Pharmacy Practice, Ahead of Print.
Acute ischemic stroke (AIS) affects over 795,000 individuals annually in the U.S. and remains a leading cause of death. Alteplase has long been the standard thrombolytic therapy for AIS, though tenecteplase has recently gained attention due to its ...
Acute ischemic stroke (AIS) affects over 795,000 individuals annually in the U.S. and remains a leading cause of death. Alteplase has long been the standard thrombolytic therapy for AIS, though tenecteplase has recently gained attention due to its ...